Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment

Area of Science:

• Neuro-oncology
• Cancer therapy
• Tumor biology

Background:

• Glioblastoma (GBM) is a highly malignant brain tumor with inadequate treatment options.
• Current therapies (surgery, chemotherapy, radiotherapy) offer poor median survival rates due to GBM's heterogeneous nature.
• The need for selective therapies targeting tumor cells is critical.

Purpose of the Study:

• To review current treatment modalities for glioblastoma.
• To discuss emerging therapeutic strategies and innovative drug regimens for GBM.
• To explore prospects for alternative glioblastoma therapies.

Main Methods:

• Literature review of preclinical and clinical trials.
• Analysis of current combination therapy approaches.
• Discussion of novel therapeutic targets and regimens.

Main Results:

• Glioblastoma treatment remains challenging, with limited efficacy of standard therapies.
• Combination therapy is evolving, with ongoing research into innovative drug regimens.
• Selective targeting of tumor cells is crucial for improving outcomes.

Conclusions:

• Despite advances, glioblastoma treatment requires further innovation.
• Emerging therapeutic approaches show promise for improving patient prognosis.
• Alternative therapies may offer new avenues for glioblastoma management.